Acute Leukemia — Trials

Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

4,655 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,259
Recruiting: 759
Ph III recruiting: 70
Growth YoY: −1.5%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (720)

clinicaltrialsPublishedShowing 301–350 of 880 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03670966	211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome	recruiting	Phase 1 / Phase 2	30	Fred Hutchinson Cancer CenterOTHER	1	Jun 22, 2026	clinicaltrials
NCT04581512	Study to Evaluate the Safety and Tolerability of EP0042	recruiting	Phase 1 / Phase 2	70	Ellipses PharmaINDUSTRY	3	Jun 22, 2026	clinicaltrials